Fact CheckerSign in

NCT03385720Recruiting

Submandibular Gland Preservation in Neck Dissection

Submandibular Gland Preservation During Neck Dissection for Oral Squamous Cell Carcinoma

Source: ClinicalTrials.gov · Last updated 30 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Trial design: a randomized controlled trial. Eligibility criteria for participants: patients with primary early stage oral squamous cell carcinoma. Exclusion criteria: cancer of the floor of the mouth. Interventions: submandibular gland is preserved during neck dissection for patients of the experimental group; submandibular gland is removed during neck dissection for patients of the control group. Primary Parameters: survival rate, mortality rate

Status (registry)
Recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
6 Dec 2017
Start date
5 Dec 2017
Primary completion date
Dec 2023
Lead sponsor
Guang-Yan Yu
NCT number
NCT03385720

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 5 Dec 2017 to the primary completion date, Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cancer of the floor of the mouth.

Who the study is looking for

  • Primary oral squamous cell carcinoma of early stage (T1N0 and T2N0).

Age in the registry: - to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Peking University School of Stomatology
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.